{"id":"inactivated-coronavac-butantan-vaccine","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site pain or swelling"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Myalgia"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Fever"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"CoronaVac is produced by inactivating SARS-CoV-2 virus particles, which are then administered to trigger both humoral (antibody) and cellular (T-cell) immune responses against viral antigens. This approach allows the immune system to recognize and neutralize the virus upon natural exposure, reducing infection risk and disease severity.","oneSentence":"An inactivated whole-virus SARS-CoV-2 vaccine that stimulates adaptive immune responses to prevent COVID-19 infection.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:15:50.137Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"COVID-19 prevention in adults and children"}]},"trialDetails":[{"nctId":"NCT05225285","phase":"PHASE3","title":"Efficacy, Immunogenicity and Safety of Inactivated Vaccine (Coronavac) Against SARS-COV2 in Children and Adolescents","status":"UNKNOWN","sponsor":"Federal University of Espirito Santo","startDate":"2022-01-21","conditions":"COVID-19","enrollment":1120}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":26,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Inactivated Coronavac/Butantan vaccine","genericName":"Inactivated Coronavac/Butantan vaccine","companyName":"Federal University of Espirito Santo","companyId":"federal-university-of-espirito-santo","modality":"Biologic","firstApprovalDate":"","aiSummary":"An inactivated whole-virus SARS-CoV-2 vaccine that stimulates adaptive immune responses to prevent COVID-19 infection. Used for COVID-19 prevention in adults and children.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}